FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On August 10, 2004
Table of Contents
Docket # Title
1977N-0094 OTC Internal Analgesic, Antipyretic & Antirheumatic Products
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
1997S-0163 Dietary Supplements, Courtesy Letters (Letters of Objection)
1998N-0359 Program priorities/Center for Food Safety & Applied Nutrition
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
1999P-2630 Establish a Daily Value for "added sugars"
1999P-5106 Identify Sources of Natural Flavorings
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
2001E-0032 Patent Extension for VISUDYNE, No. 5,095,030
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
2002N-0500 Classification of Silicone Sheeting
2002P-0317 Recall Aspartame as a Neurotoxic Drug
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2004D-0193 Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
2004M-0350 Premarket Approval for Sculptra - P030050
2004M-0356 P030026 - Vitros Immunodiagnostic Products Anti-HBc IgM Reagent Pack and Vitros Immunodiagnostic Products Anti-HBc IgM Calibrator
2004N-0133 Part 11, Electronic Record; Electronic Signatures; Public Meeting
2004N-0181 Critical Path Initiative
2004N-0264 Federal Measures to Mitigate BSE Risks: Considerations for Further Action
2004N-0330 Suicidality in Clinical Trials for Antidepressant Drugs in Pediatric Patients
2004N-0332 Agency Information Collection Activities: Proposed Collection; Comment Request; Medical Devices; Third Party Review under FDAMA
2004N-0337 Subpart D IRB Referral, Effects of a Single Dose of Dextroamphetamine in Attention Deficit Hyperactivity Disorder; A Functional Magnetic Resonance Study.
2004P-0059 Health Claim Petition: Glucosamine and Chondroitin Sulfate and Osteoarthritis
2004P-0360 ANDA drug Ferrlecit Injection 5 ml/62.5 mg of elemental iron
2004S-0233 Stimulating Innovation in Medical Technologies
1977N-0094 OTC Internal Analgesic, Antipyretic & Antirheumatic Products
ANS 10 HFD-560 to Karl Mallard Vol #: 31
ANS 11 Edward J. Hiross PhD Vol #: 31
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 14227 Enzymatic Therapy Vol #: 123
LET 14228 Enzymatic Therapy Vol #: 123
LET 14229 Perrigo Company of South Carolina Vol #: 123
LET 14230 Perrigo Company of South Carolina Vol #: 123
LET 14231 Perrigo Company of South Carolina Vol #: 123
LET 14232 Perrigo Company of South Carolina Vol #: 123
LET 14233 Perrigo Company of South Carolina Vol #: 123
LET 14234 Perrigo Company of South Carolina Vol #: 123
LET 14235 Perrigo Company of South Carolina Vol #: 123
LET 14236 Perrigo Company of South Carolina Vol #: 123
LET 14237 Enzymatic Therapy Vol #: 123
LET 14238 MT Sales (U.S.), Inc. Vol #: 123
LET 14239 Crunk LLC Vol #: 123
LET 14240 Botanic Gardens, Inc. Vol #: 123
LET 14241 Botanic Gardens, Inc. Vol #: 123
LET 14242 Botanic Gardens, Inc. Vol #: 123
LET 14243 Botanic Gardens, Inc. Vol #: 123
LET 14244 Botanic Gardens, Inc. Vol #: 123
LET 14245 Enzymatic Therapy Vol #: 123
LET 14246 Enzymatic Therapy Vol #: 123
LET 14247 Enzymatic Therapy Vol #: 123
LET 14248 Bios Biochemicals Vol #: 123
LET 14249 Enzymatic Therapy Vol #: 124
LET 14250 Enzymatic Therapy Vol #: 124
LET 14251 Enzymatic Therapy Vol #: 124
LET 14252 Arbonne International Vol #: 124
LET 14253 Integrative Therapeutics Inc. Vol #: 124
LET 14254 AdvoCare International, L.P. Vol #: 124
LET 14255 Leiner Health Products Vol #: 124
LET 14256 Leiner Health Products Vol #: 124
LET 14257 Leiner Health Products Vol #: 124
1997S-0163 Dietary Supplements, Courtesy Letters (Letters of Objection)
LET 764 HFS-800 to CCA Industries, Inc Vol #: 23
LET 765 HFS-800 to Physician Health Station LLC dba Physician Health Network Vol #: 23
LET 766 HFS-800 to Nutritional Specialties, Inc Vol #: 23
LET 767 HFS-800 to Natural Factors Nutritional Products, Inc Vol #: 23
LET 768 HFS-800 to Natural Factors Nutritional Products, Inc Vol #: 23
LET 769 HFS-800 to Spirit Science USA Inc Vol #: 23
1998N-0359 Program priorities/Center for Food Safety & Applied Nutrition
EC 143 Mrs. Karen Spettel Vol #: 9
EC 144 Ms. Judith McGeary Vol #: 9
EC 145 Mrs. Jane Jenkins Vol #: 9
EC 146 asheville yoga center Vol #: 9
EC 147 Ms. Sheril Rathke Vol #: 9
EC 148 Ms. Heather Jones Vol #: 9
EC 149 Ms. Sherree Ros Vol #: 9
EC 150 Ms. Kathleen Vallejo Vol #: 9
EC 151 Radiant Vitality Vol #: 9
EC 152 Mrs. Amy Roberts Vol #: 9
EC 153 susan e mead, m.h, inc. Vol #: 9
EC 154 Mr. Michael Austin Vol #: 9
EC 155 Ms. Nancy Smith Vol #: 9
EC 156 Ms. Mary Ellen Dudley Vol #: 9
EC 157 Mr. David Ehrensperger Vol #: 9
EC 158 Acupuncture and Zero Balancing Vol #: 9
EC 159 Weston Price Foundation Vol #: 9
EC 160 Ms. Elizabeth Thompson Vol #: 9
EC 161 Mrs. Lillian Williams Vol #: 9
EC 162 Sierra Club Vol #: 9
EC 163 Mr. David Kaufman Vol #: 9
EC 164 Mr. james moyer Vol #: 9
EC 165 Mr. Vernon Batty Vol #: 9
EC 166 Natural Marketplace Vol #: 9
EC 167 Los Angeles County Nutrition Task Force Vol #: 9
EC 168 Ms. Claudia Keel Vol #: 9
EC 169 Mr. Charlie Brenner Vol #: 9
EC 170 Mr. Jason Sullivan Vol #: 9
EC 171 NONE Vol #: 9
EC 172 robert manchester Vol #: 9
EC 173 Mr. Vince Cukrov Vol #: 9
EC 174 Ms. Sharon Donegan Vol #: 9
EC 175 Ms. Danielle White Vol #: 9
EC 176 Mr. Mark Edwards Vol #: 9
EC 177 Ms. Sarah Segal Vol #: 9
EC 178 Mr. Nelson Skinner Vol #: 9
EC 179 Ms. Lyn Gottschalk Vol #: 9
EC 180 Ms. Janice Smith Vol #: 9
EC 181 Ms. Mare Wahosi Vol #: 9
EC 182 Mrs. Sandra Cutter Vol #: 9
EC 183 Dr. Karen Larson Vol #: 9
EC 184 Mrs. Andrea Shrote Vol #: 9
EC 185 Mr. Anthony Moutis Vol #: 9
EC 186 Dr. Karen Boone Vol #: 9
EC 187 Ms. Dee Halzack Vol #: 9
EC 188 consumer of shrimp Vol #: 9
EC 189 Ms. Sandra Duggan Vol #: 9
EC 190 Ms. Jo Wilhelm Vol #: 9
EC 191 Ms. Shir Lee Cox Vol #: 9
EC 192 Mrs. Jo Tellone Vol #: 9
EC 193 Mr. David Williams Vol #: 9
EC 194 Ms. Bridget Chisholm Vol #: 9
EC 195 Mr. David Houck Vol #: 9
EC 196 Ms. Emily Bloss Vol #: 9
EC 197 Weston A. Price Foundation - Lansing Vol #: 9
EC 198 Ms. Diana Winer Vol #: 9
EC 199 Mrs. Margaret Shockley Gandy Vol #: 9
EC 200 Mr. Philip Combs Vol #: 9
EC 201 Mr. walter garvin Vol #: 9
EC 202 Mr. Erik Lords Vol #: 9
EC 203 Mr. steven lucas Vol #: 9
EC 204 Miss. Mindy McKinley Vol #: 9
EC 205 Mrs. Evalyn F. Segal Vol #: 9
EC 206 Mr. Lamont Sweisberger Vol #: 9
EC 207 Ms. Barbara Henderson Vol #: 9
EC 208 Mrs. Laurie Fisher Vol #: 9
EC 209 Mr. Chris Jordan Vol #: 9
EC 210 Ms. Danielle Kerr Vol #: 9
EC 211 Ms. Rachael Denny Vol #: 9
EC 212 Mrs. Mary Hruby Vol #: 9
EC 213 Global Policy Network Vol #: 9
EC 214 Ms. Frances Renaud Vol #: 9
EC 215 Ms. CYNTHIA ELLIOTT Vol #: 9
EC 216 Mrs. Karen Barney Vol #: 9
EC 217 Mr. James Salter Vol #: 9
EC 218 Mr. jimmy McGraw Vol #: 9
EC 219 Dr. robert morgan Vol #: 9
EC 220 Ms. June Krell Vol #: 9
EMC 17 American Society for Microbiology (ASM) Vol #: 8
1998P-0151 Introduction Of Downed Cattle Into The Food Supply
EMC 4247 H. Wagner Vol #: 304
EMC 4248 No signature Vol #: 304
EMC 4249 No signature Vol #: 304
EMC 4250 S. Norris Vol #: 304
EMC 4251 R. Austin Vol #: 304
EMC 4252 No signature Vol #: 304
EMC 4253 L. Baldwin Vol #: 304
EMC 4254 D. Damme, M.A. Vol #: 304
1999P-2630 Establish a Daily Value for "added sugars"
EMC 793 Asha Vol #: 33
1999P-5106 Identify Sources of Natural Flavorings
EMC 199 L. Partyka Vol #: 2
2000N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
C 269 Alpharma Inc. Vol #: 99
C 270 Jennie-O Turkey Store Vol #: 99
2001E-0032 Patent Extension for VISUDYNE, No. 5,095,030
APP 2
Part 2, 3, 4
University of British Columbia Vol #: 2
2001P-0075 Switch Status of Emergency Contraceptives from Rx to OTC
EMC 10222 M. Thomaston Vol #: 287
EMC 10223 L. Shopp Vol #: 287
EMC 10224 J. Howell Vol #: 287
EMC 10225 A. Thompson Vol #: 287
EMC 10226 E. Glenn Vol #: 287
EMC 10227 P. Fisk Vol #: 287
EMC 10228 S. Perry Vol #: 287
EMC 10229 S. Read Vol #: 287
EMC 10230 J. Katz Vol #: 287
EMC 10231 J. Brumm Vol #: 287
EMC 10232 K. Kubale Vol #: 287
EMC 10233 A. Haggerty Vol #: 287
EMC 10234 M. Smith, M.A. Vol #: 287
EMC 10235 J. Booze Vol #: 287
EMC 10236 M. Noble Vol #: 287
EMC 10237 No signature Vol #: 287
EMC 10238 S. Robertson Vol #: 287
2002N-0500 Classification of Silicone Sheeting
NFR 1 FDA Vol #: 1
2002P-0317 Recall Aspartame as a Neurotoxic Drug
EMC 358 Mission Possible International Vol #: 6
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
EMC 327 No signature Vol #: 8
EMC 328 J. Filegar Vol #: 8
2004D-0193 Guidance for Industry: Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
EMC 1 Form Letters Vol #: 4
EMC 2 J. Farber Vol #: 5
EMC 3 S. Betzalel Vol #: 5
EMC 4 M. Harding Vol #: 5
EMC 5 J. Maxwell Vol #: 2
EMC 6 A. Dosedal Vol #: 5
EMC 7 B. Wood Vol #: 5
EMC 8 C. Kyrish Vol #: 5
EMC 9 C. Brown Vol #: 5
EMC 10 A. Erguven Vol #: 5
EMC 11 D. Wimmer Vol #: 5
EMC 12 A. Hill Vol #: 5
EMC 13 A. Gowtam Vol #: 5
EMC 14 G. Howard Vol #: 5
EMC 15 E. Hughes Vol #: 5
EMC 16 Dr. D. Fouts Vol #: 5
EMC 17 C. Guerra,MD,FACP Vol #: 5
EMC 18 B. Montgomery Vol #: 5
EMC 19 S and A Brown Vol #: 5
EMC 20 J. Richmond Vol #: 5
EMC 21 C. Azrin Vol #: 5
EMC 22 E. Byunn Vol #: 5
EMC 23 J. Cunningham Vol #: 5
EMC 24 C. Dardis Vol #: 5
EMC 25 E. Ramsey Vol #: 5
EMC 26 K. Heppe Vol #: 5
EMC 27 E. Lopez Vol #: 5
EMC 28 R. Johnston Vol #: 5
EMC 29 M. Young Vol #: 5
EMC 30 Dunn & Sheldrick, P.S. Vol #: 5
EMC 31 K. Davies Vol #: 5
EMC 32 K. Harkins Vol #: 5
EMC 33 A. Fenelon Vol #: 5
EMC 34 J. Hague Vol #: 5
EMC 35 R. Kaerskov Vol #: 5
EMC 36 K. Meinig Vol #: 5
EMC 37 M. Fogleman Vol #: 5
EMC 38 S. Feng, M.D. Vol #: 5
EMC 39 L. Hart Vol #: 5
EMC 40 M. Earle Vol #: 5
EMC 41 S. Schwartz Vol #: 5
EMC 42 S and D Telling Vol #: 5
EMC 43 J. Adams Vol #: 5
EMC 44 K. Rogers Vol #: 5
EMC 45 M. Gail, CAE Vol #: 5
EMC 46 M. Oh Vol #: 5
EMC 47 R. Lex Vol #: 5
EMC 48 S. Linton Vol #: 5
EMC 49 S. Amoroso Vol #: 5
EMC 50 J. Brown Vol #: 5
EMC 51 K. Myrdahl Vol #: 5
EMC 52 F. Galimi Vol #: 5
EMC 53 M. Kutscher,CFA,CFP Vol #: 5
EMC 54 K. Enright Vol #: 5
EMC 55 E and G Fleming Vol #: 5
EMC 56 C. Stephen Vol #: 5
EMC 57 C. Kornmehl, MD,FACRO Vol #: 5
EMC 58 J. Strong Vol #: 5
EMC 59 V. Remolador Vol #: 5
EMC 60 K. Foust Vol #: 5
EMC 61 H. Le, MD Vol #: 5
EMC 62 L. Moreno Vol #: 5
EMC 63 D. Pfund Vol #: 5
EMC 64 C and M Biggs Vol #: 5
EMC 65 T. Hurd Vol #: 5
EMC 66 E. Thomas Vol #: 5
EMC 67 S. Barnes Vol #: 5
EMC 68 J. Hohnen Vol #: 5
EMC 69 A and B Taylor Vol #: 5
EMC 70 L. Saenz Vol #: 5
EMC 71 K. Doyle Vol #: 5
EMC 72 S. Perry Vol #: 5
EMC 73 R. Yemm Vol #: 5
EMC 74 P. Armstrong Vol #: 5
EMC 75 C. Briggeman Vol #: 5
EMC 76 M. Hershock Vol #: 5
EMC 77 Dr. J. Black Vol #: 5
EMC 78 L. Burbach Vol #: 5
EMC 79 K. Kovac Vol #: 5
EMC 80 D. Holtz Vol #: 5
EMC 81 N. Hermann Vol #: 5
EMC 82 C. and M Brown Vol #: 5
EMC 83 M. Elliott Vol #: 5
EMC 84 T Pellegrino Vol #: 5
EMC 85 R. Azrin Vol #: 5
EMC 86 L. Carter Vol #: 5
EMC 87 J. Heinemann Vol #: 5
EMC 88 C. Soviero Vol #: 5
EMC 89 D. Babbush Vol #: 5
EMC 90 K. Linza Vol #: 5
EMC 91 M. Peeks Vol #: 5
EMC 92 M. Sharma Vol #: 5
EMC 93 K and E Stack Vol #: 5
EMC 94 D. Ciardullo Vol #: 5
EMC 95 P and K Titcombe Vol #: 5
EMC 96 S. Klepper Vol #: 5
EMC 97 D. Jennings Vol #: 5
EMC 98 D. Earle Vol #: 5
EMC 99 J. Gingeleskie Vol #: 5
EMC 100 L. Hayes Vol #: 5
EMC 101 R. Ollerenshaw Vol #: 5
EMC 102 N. Matnick Vol #: 5
EMC 103 D. Gavin Vol #: 5
EMC 104 K. Downie Vol #: 5
EMC 105 S. Scarcello Vol #: 5
EMC 106 S. Kregear Vol #: 5
EMC 107 P. Buck, PhD Vol #: 5
EMC 108 R. O'Neil Vol #: 5
EMC 109 E. Ball Vol #: 5
EMC 110 T. Purchase Vol #: 5
EMC 111 S. Saini, MD Vol #: 5
EMC 112 P. Jackson Vol #: 5
EMC 113 J. Knott Vol #: 5
EMC 114 E. Villarreal Vol #: 5
EMC 115 D. Esslinger Vol #: 5
EMC 116 A. Murdock Vol #: 5
EMC 117 L. Lee Vol #: 5
EMC 118 Mr and Mrs D Ciotta Vol #: 5
EMC 119 W. Bryant Vol #: 5
EMC 120 B and E Greenspan Vol #: 5
EMC 121 J. Brown Vol #: 5
EMC 122 S. Scott Vol #: 5
EMC 123 M. Wiegand Vol #: 5
EMC 124 N. Thomas Vol #: 5
EMC 125 K. Mullarkey Vol #: 5
EMC 126 T and K Feldman Vol #: 5
EMC 127 J. Shafer Vol #: 5
EMC 128 K. Rodman Vol #: 5
EMC 129 K. Hubbard Vol #: 5
EMC 130 Dr. C. Inge Vol #: 5
EMC 131 L. Emouna Vol #: 5
EMC 132 M. Voe Vol #: 5
EMC 133 S. Leverette Vol #: 5
EMC 134 D. Sanchez Vol #: 5
EMC 135 L. Pojano Vol #: 5
EMC 136 J. Rickers and Z. Blatter Vol #: 5
EMC 137 M. Aparicio Vol #: 5
EMC 138 L. Khan Vol #: 5
EMC 139 C. Ivey Vol #: 5
EMC 140 K. Marks Vol #: 5
EMC 141 B. Chisholm Vol #: 5
EMC 142 M. Cherrin Vol #: 5
EMC 143 M. Belzer Vol #: 5
EMC 144 R. Baldwin Vol #: 5
EMC 145 L. Moss Vol #: 5
EMC 146 A. Lamberson Vol #: 5
EMC 147 K. Woodbury Vol #: 5
EMC 148 G. Bell Vol #: 5
2004M-0350 Premarket Approval for Sculptra - P030050
AAV 1 Dermik Laboratories Vol #: 1
2004M-0356 P030026 - Vitros Immunodiagnostic Products Anti-HBc IgM Reagent Pack and Vitros Immunodiagnostic Products Anti-HBc IgM Calibrator
AAV 1 Ortho-Clinical Diagnostics, Inc. Vol #: 1
2004N-0133 Part 11, Electronic Record; Electronic Signatures; Public Meeting
EMC 75
Attachment
International Assn for Pharmaceutical Technology (APV) Vol #: 6
2004N-0181 Critical Path Initiative
EMC 16 National Coalition for Cancer Survivorship (NCCS) Vol #: 3
2004N-0264 Federal Measures to Mitigate BSE Risks: Considerations for Further Action
EC 2 Miss. Rhonda Pumphrey Vol #: 7
EC 3 McDonald's Corporation Vol #: 7
EC 4 Dr. Terri White Vol #: 7
EMC 150 J. Sparks Vol #: 6
EMC 151 D. Havard Vol #: 6
EMC 152 H. Leef Vol #: 6
EMC 153 M. Mears Vol #: 6
EMC 154 C. Coulombe Vol #: 6
EMC 155 T. Robertson Vol #: 6
EMC 156 P. O'Connell Vol #: 6
EMC 157 American Meat Institute et al Vol #: 6
EMC 158 Waitaki Biosciences International Ltd. Vol #: 6
EMC 159 I. Hastings Vol #: 6
EMC 160 K. Harrison Vol #: 6
EMC 161 M. Tilschner Vol #: 6
EMC 162 K. Clark Vol #: 6
EMC 163 C. Koroll Vol #: 6
EMC 164 T. Rodman Vol #: 6
EMC 165 S. Emberson Vol #: 6
EMC 166 K. Moffitt Vol #: 6
EMC 167 T. Taylor Vol #: 6
EMC 168 Z. Gilbreath Vol #: 6
EMC 169 K. Freeza Vol #: 6
EMC 170 B. Anderson Vol #: 6
EMC 171 E. Scheid Vol #: 6
EMC 172 L. Lewallen Vol #: 6
EMC 173 E. Glenn Vol #: 6
EMC 174 B. Chapones Vol #: 6
EMC 175 M. Jerred Vol #: 6
EMC 176 J. Eggleston Vol #: 6
EMC 177 T. Hall Vol #: 6
EMC 178 P. Maly Vol #: 6
EMC 179 M. Dombek Vol #: 6
EMC 180 A. Cimino Vol #: 6
EMC 181 C. Nelson Vol #: 6
2004N-0330 Suicidality in Clinical Trials for Antidepressant Drugs in Pediatric Patients
EC 1 Mrs. Sandi Payne Vol #: 1
EC 2 Cryonic Life Insurance Company Vol #: 1
2004N-0332 Agency Information Collection Activities: Proposed Collection; Comment Request; Medical Devices; Third Party Review under FDAMA
N 1 FDA Vol #: 1
2004N-0337 Subpart D IRB Referral, Effects of a Single Dose of Dextroamphetamine in Attention Deficit Hyperactivity Disorder; A Functional Magnetic Resonance Study.
EC 1 Kaiser Permanente Vol #: 1
2004P-0059 Health Claim Petition: Glucosamine and Chondroitin Sulfate and Osteoarthritis
ANS 2 HFS-800 to Emord & Associates Vol #: 13
LET 6 Weider Nutrition International, Inc. Vol #: 13
LET 7 Weider Nutrition International, Inc. Vol #: 13
2004P-0360 ANDA drug Ferrlecit Injection 5 ml/62.5 mg of elemental iron
ACK 1 AAC Consulting Group Vol #: 1
CP 1
Attachment A, B
AAC Consulting Group Vol #: 1
2004S-0233 Stimulating Innovation in Medical Technologies
C 3 National Venture Capital Association Vol #: 1

Page created on August 11, 2004 dp

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management